Yahoo Web Search

Search results

1. • Argenx soars on CIDP shot approval

     Investing.com via Yahoo Singapore Finance· 7 days ago

     Argenx expects annual net revenue per patient per year of around $450,000 for U.S. CIDP patient. UBS keeps a ‘neutral’ rating for now, but lifts its 12-month target price ...